Abstract:Background Despite the importance of diagnosis and treatment, obstructive sleep apnea (OSA) remains a vastly underdiagnosed condition; this is partially due to current OSA identification methods and a complex and fragmented diagnostic pathway. Objective This prospective, single-arm, multistate feasibility pilot study aimed to understand the journey in a nonreferred sample of participants through the fully remote OSA screening and diagnostic and treatment pathway, using the Primasun Sleep Apnea Program (formally, Verily Sleep Apnea Program). Methods Participants were recruited online from North Carolina and Texas to participate in the study entirely virtually. Eligible participants were invited to schedule a video telemedicine appointment with a board-certified sleep physician who could order a home sleep apnea test (HSAT) to be delivered to the participant's home. The results were interpreted by the sleep physician and communicated to the participant during a second video telemedicine appointment. The participants who were diagnosed with OSA during the study and prescribed a positive airway pressure (PAP) device were instructed to download an app that provides educational and support-related content and access to personalized coaching support during the study’s 90-day PAP usage period. Surveys were deployed throughout the study to assess baseline characteristics, prior knowledge of sleep apnea, and satisfaction with the program. Results For the 157 individuals who were ordered an HSAT, it took a mean of 7.4 (SD 2.6) days and median 7.1 days (IQR 2.0) to receive their HSAT after they completed their first televisit appointment. For the 114 individuals who were diagnosed with OSA, it took a mean of 13.9 (SD 9.6) days and median 11.7 days (IQR 10.1) from receiving their HSAT to being diagnosed with OSA during their follow-up televisit appointment. Overall, the mean and median time from the first televisit appointment to receiving an OSA diagnosis was 21.4 (SD 9.6) days and 18.9 days (IQR 9.2), respectively. For those who were prescribed PAP therapy, it took a mean of 8.1 (SD 9.3) days and median 6.0 days (IQR 4.0) from OSA diagnosis to PAP therapy initiation. Conclusions These results demonstrate the possibility of a highly efficient, patient-centered pathway for OSA workup and treatment. Such findings support pathways that could increase access to care, reduce loss to follow-up, and reduce health burden and overall cost. The program’s ability to efficiently diagnose patients who otherwise may have not been diagnosed with OSA is important, especially during a pandemic, as the United States shifted to remote care models and may sustain this direction. The potential economic and clinical impact of the program’s short and efficient journey time and low attrition rate should be further examined in future analyses. Future research also should examine how a fast and positive diagnosis experience impacts success rates for PAP therapy initiation and adherence. Trial Registration ClinicalTrials.gov NCT04599803; https://clinicaltrials.gov/ct2/show/NCT04599803

A new telemedicine-based sleep service using WatchPAT® ONE for patients with suspected OSA: what does the patient experience?

[Evaluation of a portable device based on peripheral arterial tone in the detection of obstructive sleep apnea].

Evaluation of Watch PAT As a Diagnosing Test for Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Accuracy of WatchPAT for the Diagnosis of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease

Reducing cost and time to diagnosis and treatment of obstructive sleep apnea using ambulatory sleep study: a Singapore sleep centre experience

Comparison of polysomnography and the Watch-PAT in the diagnosis of obstructive sleep apnea

Assessment of Patient Journey Metrics for Users of a Digital Obstructive Sleep Apnea Program: Single-Arm Feasibility Pilot Study

One-Year Adherence to Continuous Positive Airway Pressure With Telemonitoring in Sleep Apnea Hypopnea Syndrome: A Randomized Controlled Trial

0448 Telemedicine Management of Obstructive Sleep Apnea Disorder: A Randomized Controlled Trial

Proactive telemedicine monitoring of sleep apnea treatment improves adherence in people with stroke- a randomized controlled trial (HOPES study)

Pilot study of positive airway pressure usage, patient journey and program engagement for users of a digital obstructive sleep apnea program

Advancements in Home-Based Devices for Detecting Obstructive Sleep Apnea: A Comprehensive Study

Technologic advances in the assessment and management of obstructive sleep apnoea beyond the apnoea-hypopnoea index: a narrative review

SLEEP STAGING BASED ON AUTONOMIC SIGNALS - A MULTI-CENTER BLINDED VALIDATION STUDY

Personalized Treatment for Obstructive Sleep Apnea: Beyond CPAP

Feasibility Study of Telemedicine Model for Diagnosis and Treatment of Patients with Obstructive Sleep Apnea Hypopnea Syndrome in China

Study on Adherence to Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Using Real-World Big Data in a Telemedicine Management System

OSA diagnosis goes wearable: are the latest devices ready to shine?

Management and Treatment of Patients With Obstructive Sleep Apnea Using an Intelligent Monitoring System Based on Machine Learning Aiming to Improve Continuous Positive Airway Pressure Treatment Compliance: Randomized Controlled Trial

Automatic monitoring of obstructive sleep apnea based on multi-modal signals by phone and smartwatch

Validation of a new, minimally-invasive, software smartphone device to predict sleep apnea and its severity: transversal study